Caplin Point Laboratories Ltd
NSE:CAPLIPOINT

Watchlist Manager
Caplin Point Laboratories Ltd Logo
Caplin Point Laboratories Ltd
NSE:CAPLIPOINT
Watchlist
Price: 1 826.2 INR -1.53% Market Closed
Market Cap: 138.8B INR

Net Margin

28.9%
Current
Improving
by 1.9%
vs 3-y average of 27%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
28.9%
=
Net Income
₹5.9B
/
Revenue
₹20.4B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
28.9%
=
Net Income
₹5.9B
/
Revenue
₹20.4B

Peer Comparison

Country Company Market Cap Net
Margin
IN
Caplin Point Laboratories Ltd
NSE:CAPLIPOINT
138.8B INR
Loading...
US
Eli Lilly and Co
NYSE:LLY
982.2B USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
526.1B USD
Loading...
CH
Roche Holding AG
SIX:ROG
277.8B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
217.9B GBP
Loading...
CH
Novartis AG
SIX:NOVN
221.8B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
270.7B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
213.9B USD
Loading...
US
Pfizer Inc
NYSE:PFE
145.8B USD
Loading...
No Stocks Found

Market Distribution

Higher than 91% of companies in India
Percentile
91th
Based on 3 257 companies
91th percentile
28.9%
Low
-204 400% — 3.3%
Typical Range
3.3% — 13.3%
High
13.3% — 567 451.5%
Distribution Statistics
India
Min -204 400%
30th Percentile 3.3%
Median 7.3%
70th Percentile 13.3%
Max 567 451.5%

Caplin Point Laboratories Ltd
Glance View

Nestled in the bustling business corridors of Chennai, Caplin Point Laboratories Ltd. emerged quietly yet resolutely from its humble origins in 1990. With foresight and strategic maneuvering, the company embarked on a global journey, primarily serving markets across the African, Latin American, and Southeast Asian regions. The firm specializes in a wide array of pharmaceutical products, encompassing everything from injectables and ophthalmics to oral solids and liquids. By focusing on markets that were often overlooked by larger pharmaceutical giants, Caplin Point carved out a niche that allowed it to flourish with minimal competition. The company's business model hinges on leveraging cost-effective manufacturing paired with a deep understanding of diverse regulatory environments, deftly navigating these to establish a loyal customer base amidst underrepresented geographies. The revenue streams of Caplin Point Laboratories are primarily fueled by its ability to adapt product lines to meet the specific needs of each market it serves. This adaptability, combined with a robust distribution network, facilitates the swift movement of goods—ensuring prompt delivery to consumers who rely on its products for basic health needs. Through strategic partnerships and continual investment in research and development, Caplin Point enhances its capacity for innovation, allowing it to advance the quality and range of its pharmaceutical offerings. Furthermore, the company has steadily expanded into regulated markets with its sights set on injectables and has plans for further diversification. This strategic orientation underscores its ambition to transition from a regional powerhouse to a formidable player on the broader global stage.

CAPLIPOINT Intrinsic Value
1 161.93 INR
Overvaluation 36%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
28.9%
=
Net Income
₹5.9B
/
Revenue
₹20.4B
What is Caplin Point Laboratories Ltd's current Net Margin?

The current Net Margin for Caplin Point Laboratories Ltd is 28.9%, which is above its 3-year median of 27%.

How has Net Margin changed over time?

Over the last 3 years, Caplin Point Laboratories Ltd’s Net Margin has increased from 24.1% to 28.9%. During this period, it reached a low of 24.1% on Aug 30, 2022 and a high of 28.9% on Oct 30, 2025.

Back to Top